August 5th 2025, 4:00pm
An expert helps patients with metastatic breast cancer understand treatment sequencing, biomarker testing and emerging options to support decision-making.
July 15th 2025, 8:00pm
Dr. Masey Ross explains how biomarker testing, patient history, and quality-of-life concerns guide treatment decisions in metastatic breast cancer.
July 9th 2025, 4:00pm
Dr. Alicia Arnold and Dr. Priyanka Raval discuss first- and later-line treatment options for those with ER-positive, HER2-negative stage 4 breast cancer.
June 10th 2025, 4:00pm
Dr. Mabel Mardones educates patients on breast cancer subtypes, as well as treatment options for those with ER-positive, HER2-negative disease.
April 25th 2025, 7:00pm
Dr. Brian Czerniecki, of Moffitt Cancer Center, led a CURE Educated Patient® Updates in Metastatic Breast Cancer event, and provided subsequent updates.
November 27th 2024, 4:00pm
An expert discusses the next steps for patients with metastatic breast cancer after their disease no longer responds to hormone therapy.
October 21st 2024, 1:00pm
An expert discussed the importance of patients learning about their specific type of breast cancer to understand potential treatment options.
October 15th 2024, 3:00pm
An expert discussed the importance of biomarkers in guiding treatment decisions for patients with metastatic breast cancer.
September 19th 2024, 7:00pm
Through communication and education, patients with metastatic breast cancer may be able to balance treatment with quality of life.
August 9th 2024, 1:00pm
An expert explained the importance of understanding different subtypes of metastatic breast cancer and available treatment options based on biomarker testing.
FDA Fast Tracks Vaccine For Some With Breast Cancer
What Patients With Lung Cancer Need to Know About EGFR PACC Mutations
FDA Approves Inlexzo for Some With Non–Muscle Invasive Bladder Cancer
Lunsumio plus Polivy Associated With Responses in MCL